Evonik Industries (ETR:EVK) stock price target increased to 28.00EUR, issued a ratings update earlier today by BNP PARIBAS
- Updated: October 8, 2016
Having a price of 30.59EUR, Evonik Industries (ETR:EVK) traded -4.29% lower on the day. With the last close up 7.17% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. EVK has recorded a 50-day average of 2.35EUR and a two hundred day average of 2.09EUR. Trade Volume was down over the average, with 3,241 shares of EVK changing hands under the typical 7,166
Reporting a potential downside of -0.08%, BNP PARIBAS upped the price target of Evonik Industries (ETR:EVK) to 28.00EUR
On 10/05/2016, BNP PARIBAS released a statement on Evonik Industries (ETR:EVK) upped the target price from 0.00EUR to 28.00EUR that suggested a downside of -0.08%.
Recent Performance Chart
Evonik Industries has PE ratio of 3.21 with a one year low of 1.35EUR and a one year high of 3.22EUR and has a market capitalization of 0 EUR.
General Company Details For Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company's activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company's sites, among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.